EUVIMEDEUVIMED entdecken
Crossref

Rhodanine-Inspired Development of Dual-Action Mycobacterium tuberculosis Protein Tyrosine Phosphatase B Inhibitors

Haofan Shao, Xiaoyu Wu, Shihao Cheng, Bin Wang, Xi Chen, Yixuan Zheng, Zhenfa Yang, Jiang Li, Fei Ye, Yu Lu, Haihong Huang, Zhenhuang Ge und 1 weitere

Journal of Medicinal Chemistry · 28.05.2026 · 69 (10) · 12223-12239

DOI: 10.1021/acs.jmedchem.6c00103 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, online erschienen am 06.05.2026. Verfasst von Haofan Shao und 12 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Respiratory Health and Multimorbidity, Institute of Materia Medica, Chinese Academy of Medical Sciences & Peking Union Medica…. Hauptthemen laut MEDLINE: Mycobacterium tuberculosis, Rhodanine, Antitubercular Agents, Enzyme Inhibitors. Die Arbeit nennt 34 Literaturangaben. Gefördert von: Chinese Academy of Medical Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mycobacterium tuberculosisRhodanineAntitubercular AgentsEnzyme InhibitorsProtein Tyrosine PhosphatasesBacterial ProteinsAnimalsMiceHumansStructure-Activity RelationshipMolecular Docking SimulationMicrobial Sensitivity Tests

Substanzen

RhodanineAntitubercular AgentsEnzyme InhibitorsProtein Tyrosine PhosphatasesBacterial Proteins

Autor:innen und Institutionen

  • State Key Laboratory of Respiratory Health and Multimorbidity, Institute of Materia Medica, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100050, China.
  • Beijing Key Laboratory for Key Technologies in Tuberculosis Prevention and Control, Institute of Materia Medica, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100050, China.
  • School of Life Sciences, Sun Yat-sen University, Guangzhou, Guangdong 510275, China.
  • Institute of Materia Medica, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100050, China.
  • Beijing Key Laboratory for Key Technologies in Tuberculosis Prevention and Control, Beijing Tuberculosis and Thoracic Tumor Research Institute, Beijing Chest Hospital, Capital Medical University, Beijing 101149, China.

ORCID-Profile: Dongfeng Zhang

Förderung

  • Chinese Academy of Medical Sciences

Zitieren

APA

Shao, H., Wu, X., Cheng, S., Wang, B., Chen, X., Zheng, Y., Yang, Z., Li, J., Ye, F., Lu, Y., Huang, H., Ge, Z., & Zhang, D. (2026). Rhodanine-Inspired Development of Dual-Action Mycobacterium tuberculosis Protein Tyrosine Phosphatase B Inhibitors. Journal of Medicinal Chemistry, 69(10), 12223-12239. https://doi.org/10.1021/acs.jmedchem.6c00103

Vancouver

Shao H, Wu X, Cheng S, Wang B, Chen X, Zheng Y, et al. Rhodanine-Inspired Development of Dual-Action Mycobacterium tuberculosis Protein Tyrosine Phosphatase B Inhibitors. Journal of Medicinal Chemistry. 2026;69(10):12223-12239. doi:10.1021/acs.jmedchem.6c00103

BibTeX
@article{Shao2026,
  author = {Shao, Haofan and Wu, Xiaoyu and Cheng, Shihao and Wang, Bin and Chen, Xi and Zheng, Yixuan and Yang, Zhenfa and Li, Jiang and Ye, Fei and Lu, Yu and Huang, Haihong and Ge, Zhenhuang and Zhang, Dongfeng},
  title = {Rhodanine-Inspired Development of Dual-Action Mycobacterium tuberculosis Protein Tyrosine Phosphatase B Inhibitors},
  journal = {Journal of Medicinal Chemistry},
  year = {2026},
  volume = {69},
  number = {10},
  pages = {12223--12239},
  doi = {10.1021/acs.jmedchem.6c00103}
}
Kostenlos starten →